Lumacaftor Acid D4 | CAS 1961281-89-9 - Request Quote
Lumacaftor Acid D4
| SZ CAT No: | SZ-L117D03 |
| CAS No | 1961281-89-9 |
| Mol.F. | C11H4D4F2O4 |
| Mol.Wt. | 246.2 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lumacaftor Acid D4 is chemically 1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)cyclopropane-1-carboxylic-2,2,3,3-d4 acid. Lumacaftor Acid D4 is supplied with detailed characterization data compliant with regulatory guideline. Lumacaftor Acid D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lumacaftor.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1961281-89-9
Purchase 1961281-89-9
Order 1961281-89-9
Enquire 1961281-89-9
price of 1961281-89-9
1961281-89-9 Supplier
1961281-89-9 Manufacturer
1961281-89-9 Exporter
buy high quality Lumacaftor Acid D4
Purchase Lumacaftor Acid D4
Lumacaftor Acid D4 suppliers
Lumacaftor Acid D4 manufacturers
Lumacaftor Acid D4 price
Order Lumacaftor Acid D4
Enquire Lumacaftor Acid D4
Lumacaftor Acid D4 cost
Lumacaftor Acid D4 Supplier
Lumacaftor Acid D4 Distributor
Lumacaftor Acid D4 for Method Validation
Lumacaftor Reference Standard
Lumacaftor Acid D4 for ANDA Filing
Lumacaftor Acid D4 for Forced Degradation Studies
Lumacaftor Acid D4 Identification Standards
Lumacaftor Acid D4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.